Citations (10)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Yo Muraki, Takako Naito, Kimio Tohyama, Sachio Shibata, Kanako Kuniyeda, Yasunori Nio, Masatoshi Hazama & Takanori Matsuo. (2019) Improvement of pulmonary arterial hypertension, inflammatory response, and epithelium injury by dual activation of cAMP/cGMP pathway in a rat model of monocrotaline-induced pulmonary hypertension. Bioscience, Biotechnology, and Biochemistry 83:6, pages 1000-1010.
Read now
Read now
Olivier Defert & Sandro Boland. (2017) Rho kinase inhibitors: a patent review (2014 – 2016). Expert Opinion on Therapeutic Patents 27:4, pages 507-515.
Read now
Read now
Mayank Sardana, Matthew Moll & Harrison W Farber. (2016) Pharmacokinetic drug evaluation of selexipag for the treatment of pulmonary arterial hypertension. Expert Opinion on Drug Metabolism & Toxicology 12:12, pages 1513-1520.
Read now
Read now
Articles from other publishers (7)
Ling Zhu, Ye-li Li, Zhi-qiang Qian, Liang Hua, Yun Yue & Dan-li Yang. (2021) Osthole improves pulmonary artery hypertension by inducing apoptosis in pulmonary artery smooth muscle cells. Journal of Pharmacy and Pharmacology.
Crossref
Crossref
Magdalena Jasińska-Stroschein & Daria Orszulak-Michalak. (2021) Reporting experimental studies on animals – The problems with translating of outcomes to clinical benefits. Methodological and statistical considerations: The example of pulmonary hypertension. European Journal of Pharmacology 897, pages 173952.
Crossref
Crossref
Jin-Ha Yoon, Thi-Thao-Linh Nguyen, Van-An Duong, Kwang-Hoon Chun & Han-Joo Maeng. (2020) Determination of KD025 (SLx-2119), a Selective ROCK2 Inhibitor, in Rat Plasma by High-Performance Liquid Chromatography-Tandem Mass Spectrometry and Its Pharmacokinetic Application. Molecules 25:6, pages 1369.
Crossref
Crossref
Jahidur Rashid, Eva Nozik-Grayck, Ivan F. McMurtry, Kurt R. Stenmark & Fakhrul Ahsan. (2019) Inhaled combination of sildenafil and rosiglitazone improves pulmonary hemodynamics, cardiac function, and arterial remodeling. American Journal of Physiology-Lung Cellular and Molecular Physiology 316:1, pages L119-L130.
Crossref
Crossref
Katarzyna Sztuka, Daria Orszulak-Michalak & Magdalena Jasińska-Stroschein. (2018) Systematic review and meta-analysis of interventions tested in animal models of pulmonary hypertension. Vascular Pharmacology 110, pages 55-63.
Crossref
Crossref
Yo Muraki, Midori Yamasaki, Hirohisa Takeuchi, Kimio Tohyama, Noriyasu Sano & Takanori Matsuo. (2018) Fluorescent Imaging Analysis for Distribution of Fluorescent Dye Labeled- or Encapsulated-Liposome in Monocrotaline-Induced Pulmonary Hypertension Model Rat. Chemical and Pharmaceutical Bulletin 66:3, pages 270-276.
Crossref
Crossref
Gesheng Cheng, Xingye Wang, Yongxin Li & Lu He. (2017) Let-7a-transfected mesenchymal stem cells ameliorate monocrotaline-induced pulmonary hypertension by suppressing pulmonary artery smooth muscle cell growth through STAT3-BMPR2 signaling. Stem Cell Research & Therapy 8:1.
Crossref
Crossref